Navigation Links
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Date:8/21/2008

ore than 40 countries for liver cancer and in more than 70 countries for the treatment of patients with advanced kidney cancer. Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators as a single agent or combination treatment in a wide range of cancers, including metastatic melanoma, lung cancer, breast cancer and as an adjuvant therapy for kidney cancer.

Important Safety Considerations For Patients Taking Nexavar

Based on the currently approved U.S. package insert for the treatment of patients with unresectable hepatocellular carcinoma, hypertension may occur early in the course of therapy and blood pressure should be monitored weekly during the first six weeks of therapy and treated as needed. Bleeding with a fatal outcome from any site was reported in 2.4% for Nexavar and 4% in placebo. The incidence of treatment-emergent cardiac ischemia/infarction was 2.7% for Nexavar vs. 1.3% for placebo. Most common adverse events reported with Nexavar in patients with unresectable HCC were diarrhea, fatigue, abdominal pain, weight loss, anorexia, nausea and hand-foot skin reaction. Grade 3/4 adverse events were 45% for Nexavar vs. 32% for placebo. Women of child-bearing potential should be advised to avoid becoming pregnant and advised against breast-feeding. In cases of any severe or persistent side effects, temporary treatment interruption, dose modification or permanent discontinuation should be considered.

For information about Nexavar including U.S. Nexavar prescribing information, visit http://www.nexavar.com or call 1.866.NEXAVAR (1.866.639.2827).

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Ba
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCarePharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
2. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
6. Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
7. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
8. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... BEIJING, May 6, 2015 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in China, today ... of 2015. First Quarter 2015 Financial ... quarter of 2015 increased by 25.0% to $70.4 million ... , Gross profit increased by 18.9% to $45.9 ...
(Date:5/6/2015)... Calif. , May 6, 2015 ... biotechnology company in the emerging field of regenerative ... a meeting with the investment community to review ... cells) in spinal cord injury on Friday, May ... 1/2a clinical trial and future planned clinical activities ...
(Date:5/6/2015)... -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) today ... 2015.  The net loss and the loss from operations ... million, respectively, compared to $10.7 million and $8.8 million ... 31, 2015, Alexza had consolidated cash, cash equivalents, marketable ... "We continue to focus on ways in which to ...
Breaking Medicine Technology:China Biologic Reports Financial Results for the First Quarter of 2015 2China Biologic Reports Financial Results for the First Quarter of 2015 3China Biologic Reports Financial Results for the First Quarter of 2015 4China Biologic Reports Financial Results for the First Quarter of 2015 5China Biologic Reports Financial Results for the First Quarter of 2015 6China Biologic Reports Financial Results for the First Quarter of 2015 7China Biologic Reports Financial Results for the First Quarter of 2015 8China Biologic Reports Financial Results for the First Quarter of 2015 9China Biologic Reports Financial Results for the First Quarter of 2015 10China Biologic Reports Financial Results for the First Quarter of 2015 11China Biologic Reports Financial Results for the First Quarter of 2015 12China Biologic Reports Financial Results for the First Quarter of 2015 13China Biologic Reports Financial Results for the First Quarter of 2015 14China Biologic Reports Financial Results for the First Quarter of 2015 15China Biologic Reports Financial Results for the First Quarter of 2015 16China Biologic Reports Financial Results for the First Quarter of 2015 17China Biologic Reports Financial Results for the First Quarter of 2015 18Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10
(Date:5/7/2015)... Sky Hollywood Slots ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... , According to the Las Vegas Convention and Visitors Authority, ... But what’s even more shocking is that those people spent ...
(Date:5/6/2015)... Neb. (PRWEB) May 07, 2015 A poker run ... is scheduled May 30. , The poker run will start at ... at 12:15 p.m. , During the poker run, participants will ... to have the best poker hand at the end of the ... then run 172 miles to York Offsides Tavern, Fairmont American Legion, ...
(Date:5/6/2015)... 2015 The dates have been selected ... Game Changers Summit 2015 , an Information & Technology ... Methodist Communications. Join the international gathering September 17-19 at ... communication leaders from around the globe will speak and ... throughout the developing world. , The theme of the ...
(Date:5/6/2015)... MJNational LLC strengthens its consultant agreement to ... ™ platform. This exciting new SMS platform creates quite ... / Services. Now you can reach out to ... services and ticker symbol through an easy to use ... will provide managed support and services to advance the ...
(Date:5/6/2015)... CA (PRWEB) May 06, 2015 On ... Celebrities on Plastic Surgery ,” compiled quotes about ... includes Jennifer Aniston, pop singer Iggy Azalea, and Gwyneth ... their sentiments about having plastic surgery themselves; ... about society and its expectations of youth and beauty. ...
Breaking Medicine News(10 mins):Health News:A Social Casino Game that Focuses on Slots Was Featured on NewsWatch Television 2Health News:Updated Contacts: Poker Run Fundraiser to Benefit National Veterans Golden Age Games 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 3Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2
... Ariz. Aug. 31, 2010 The first study of ... they affect cell growth has identified two potential anti-cancer drug ... Research Institute (TGen) published this month in the journal ... cancer lesions that occur most frequently in the bones of ...
... in road accidents on the basis of the time taken ... reducing the time between an accident taking place and ... minutes would cut the risk of death by one-third. ... services arrive is 25 minutes in Spain", Roco Snchez-Mangas, co-author ...
... (September 1, 2010) Faith based schools are on ... But are religious values at odds with legislation on ... Management Administration and Leadership published by SAGE shows what ... diverge, with unfortunate consequences for gay students and staff. ...
... broad defense against cancer recurrence after surgical resection. However, ... from which regimen of anticancer drugs, if at all. ... September edition of the Journal of Thoracic Oncology ... non-small cell lung cancer (NSCLC) based on the histoculture ...
... Young adults who get fewer than eight hours of ... combination of high levels of depressive and anxious symptoms, according ... journal SLEEP . Using an average self-reported nightly ... the study found a linear association between sleep durations of ...
... Hundreds of millions of euros are being saved ... community pharmacists rather than going straight to their doctors, ... September) at the annual conference of the International Pharmaceutical ... was freed up in one year for other healthcare ...
Cached Medicine News:Health News:TGen finds therapeutic targets for rare cancer in children 2Health News:10 minutes could prevent one-third of road deaths 2Health News:Keeping faith -- schools must balance ethos with equality 2Health News:Lung cancer survival rates improved through use of individualized chemotherapy 2Health News:Study links shorter sleep durations with greater risks of mental distress in young adults 2Health News:Study links shorter sleep durations with greater risks of mental distress in young adults 3Health News:Health advice from pharmacists saves hundreds of millions of euros 2Health News:Health advice from pharmacists saves hundreds of millions of euros 3
... The Equalizer With 384 Well Plate Capability ... features of the original Equalizerexpandable and equal tip ... and in-lab calibration capabilities. In addition, this model ... to 4.5mm for loading and accessing many gels ...
... Exp Expandable Tip System A lower cost ... you to perform multi-sample transfers between two different ... a knob, tip spacing can be quickly and ... or 96 well plates. Ergonomic Design for ...
Packaging: Set includes: Eight-channel pipette (10.8 mm with 0.5-5.0 μl capacity) 25 PrismStrip 96 tips with rack 2 FlexPlates with a holder...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Medicine Products: